Literature DB >> 16609756

Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada -- an epidemiological study from 1964-2002.

Jeremy R Parfitt1, Zoran Miladinovic, David K Driman.   

Abstract

BACKGROUND: The increasing incidence of esophageal and proximal gastric (cardia) adenocarcinoma and the decreasing incidence of distal gastric (antropyloric) adenocarcinoma has been documented in several populations. The aim of the present study was to examine incidence trends of these neoplasms in Ontario, Canada's most populous province, over a 39-year period.
METHODS: Analyses were based on data obtained from the Ontario Cancer Registry of Cancer Care Ontario. Number of cases and rates per 100,000 age-adjusted to the 1996 Canadian standard, were obtained for all esophageal and gastric carcinoma cases reported between 1964 and 2002. Rates were grouped into five-year periods to analyze trends over the 39-year period. Point and 95% CI estimates of average annual percentage change in incidence rates were calculated with a log-linear regression model.
RESULTS: The incidence of adenocarcinoma of the distal esophagus increased in men and women (average annual increase of 9.5% in men; 4.3% in women). The incidence of adenocarcinoma of the cardia increased in men and women (average annual increase of 7.3% in men; 5.8% in women). The incidence of antropyloric adenocarcinoma increased in men and women (average annual increase of 4.4% in men; 5.3% in women). The incidence of esophageal squamous cell carcinoma remained stable.
CONCLUSIONS: There has been a significant increase in the incidence of adenocarcinoma around the gastroesophageal junction in men over the 39-year study period. The increase in incidence of distal gastric adenocarcinoma is unexpected and may relate to a reclassification phenomenon, immigration trends in Ontario and a rising incidence of diffuse/signet ring cell adenocarcinoma.

Entities:  

Mesh:

Year:  2006        PMID: 16609756      PMCID: PMC2659904          DOI: 10.1155/2006/175751

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  25 in total

1.  The epidemiology of oesophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma?

Authors:  E I Sihvo; J T Salminen; O J Rämö; J A Salo
Journal:  Scand J Gastroenterol       Date:  2000-10       Impact factor: 2.423

Review 2.  Esophageal cancer.

Authors:  Peter C Enzinger; Robert J Mayer
Journal:  N Engl J Med       Date:  2003-12-04       Impact factor: 91.245

3.  Overweight and obesity mortality trends in Canada, 1985-2000.

Authors:  Peter T Katzmarzyk; Christopher I Ardern
Journal:  Can J Public Health       Date:  2004 Jan-Feb

4.  Canada's teenagers less likely to smoke now than in 1999.

Authors:  David Spurgeon
Journal:  BMJ       Date:  2004-08-21

Review 5.  Differential trends in the intestinal and diffuse types of gastric carcinoma.

Authors:  Angelo Sidoni
Journal:  Arch Pathol Lab Med       Date:  2005-03       Impact factor: 5.534

Review 6.  Gastric cancer epidemiology and risk factors.

Authors:  Jon R Kelley; John M Duggan
Journal:  J Clin Epidemiol       Date:  2003-01       Impact factor: 6.437

7.  Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States.

Authors:  Ai Kubo; Douglas A Corley
Journal:  Am J Gastroenterol       Date:  2004-04       Impact factor: 10.864

Review 8.  Epidemiology of upper gastrointestinal malignancies.

Authors:  Katherine D Crew; Alfred I Neugut
Journal:  Semin Oncol       Date:  2004-08       Impact factor: 4.929

9.  Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type.

Authors:  Donald Earl Henson; Christopher Dittus; Mamoun Younes; Hong Nguyen; Jorge Albores-Saavedra
Journal:  Arch Pathol Lab Med       Date:  2004-07       Impact factor: 5.534

10.  Population attributable risks of esophageal and gastric cancers.

Authors:  Lawrence S Engel; Wong-Ho Chow; Thomas L Vaughan; Marilie D Gammon; Harvey A Risch; Janet L Stanford; Janet B Schoenberg; Susan T Mayne; Robert Dubrow; Heidrun Rotterdam; A Brian West; Martin Blaser; William J Blot; Mitchell H Gail; Joseph F Fraumeni
Journal:  J Natl Cancer Inst       Date:  2003-09-17       Impact factor: 13.506

View more
  15 in total

1.  Comparison of advanced adenocarcinomas of esophagogastric junction and distal stomach in Japanese patients.

Authors:  Akiko Kawano; Takako Eguchi Nakajima; Ichiro Oda; Nobukazu Hokamura; Satoru Iwasa; Ken Kato; Tetsuya Hamaguchi; Yasuhide Yamada; Hirofumi Fujii; Yasuhiro Shimada
Journal:  Gastric Cancer       Date:  2013-02-24       Impact factor: 7.370

2.  HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment.

Authors:  Pamela L Kunz; Amirkaveh Mojtahed; George A Fisher; James M Ford; Daniel T Chang; Raymond R Balise; Charles D Bangs; Athena M Cherry; Reetesh K Pai
Journal:  Appl Immunohistochem Mol Morphol       Date:  2012-01

3.  Accuracy of hydro-multidetector row CT in the local T staging of oesophageal cancer compared to postoperative histopathological results.

Authors:  Ahmed Ba-Ssalamah; Wolfgang Matzek; Susanne Baroud; Nina Bastati; Johannes Zacherl; Sebastian F Schoppmann; Michael Hejna; Fritz Wrba; Michael Weber; Christian J Herold; Richard M Gore
Journal:  Eur Radiol       Date:  2011-06-28       Impact factor: 5.315

4.  A population-based analysis of esophageal and gastric cardia adenocarcinomas in Ontario, Canada: incidence, risk factors, and regional variation.

Authors:  Jill Tinmouth; Josh Green; Yoo-Joung Ko; Ying Liu; Lawrence Paszat; Rinku Sutradhar; Linda Rabeneck; David Urbach
Journal:  J Gastrointest Surg       Date:  2011-03-16       Impact factor: 3.452

5.  Esophageal cancer in Canada: trends according to morphology and anatomical location.

Authors:  Michael C Otterstatter; James D Brierley; Prithwish De; Larry F Ellison; Maureen Macintyre; Loraine D Marrett; Robert Semenciw; Hannah K Weir
Journal:  Can J Gastroenterol       Date:  2012-10       Impact factor: 3.522

Review 6.  Reflux esophagitis, high-grade neoplasia, and early Barrett's carcinoma-what is the place of the Merendino procedure?

Authors:  A H Hölscher; D Vallböhmer; C Gutschow; E Bollschweiler
Journal:  Langenbecks Arch Surg       Date:  2008-11-07       Impact factor: 3.445

7.  Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999.

Authors:  M Bashash; A Shah; G Hislop; A Brooks-Wilson; N Le; C Bajdik
Journal:  Can J Gastroenterol       Date:  2008-02       Impact factor: 3.522

Review 8.  Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease.

Authors:  Matthew F Buas; Thomas L Vaughan
Journal:  Semin Radiat Oncol       Date:  2013-01       Impact factor: 5.934

9.  Prevalence of symptoms and use of medication for gastroesophageal reflux in an Australian community.

Authors:  David I Watson; Carolyn J Lally
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

10.  Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands.

Authors:  S Kroep; I Lansdorp-Vogelaar; J H Rubenstein; V E P P Lemmens; E B van Heijningen; N Aragonés; M van Ballegooijen; J M Inadomi
Journal:  Am J Gastroenterol       Date:  2013-12-17       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.